Breaking News, Financial News

Financial Report: Dr. Reddy’s 4Q10

North America revenue growth was 18% for the year, with 11 new product launches.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Reddy’s 4Q10 4Q Revenues: $453.0 million (+23%) 4Q Earnings: $75.0 million (+101%) FY Revenues: $1.7 billion (+6%) FY Earnings: $248.0 million (earnings were $24.0 million FY10) Comments: North America revenue growth was 18% for the year, with 11 new product launches. Russia had revenue growth of 29% with volume growth and OTC initiatives. India had revenue growth of 15%, with continued growth of key brands and new products. Germany revenue was down 17% in Euro terms, but ha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters